Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-26

Clinical Trial Update: Preference Tiotropium Respimat Study in COPD

View source ↗

Summary

This entry reports the completion of a Boehringer Ingelheim clinical trial evaluating tiotropium Respimat in chronic obstructive pulmonary disease and notes tha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tiotropium Respimat (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2015-03-26